Document_and_Entity_Informatio
Document and Entity Information | 9 Months Ended | |
Sep. 30, 2013 | Oct. 24, 2013 | |
Document and Entity Information | ' | ' |
Entity Registrant Name | 'HITTITE MICROWAVE CORP | ' |
Entity Central Index Key | '0001130866 | ' |
Document Type | '10-Q | ' |
Document Period End Date | 30-Sep-13 | ' |
Amendment Flag | 'false | ' |
Current Fiscal Year End Date | '--12-31 | ' |
Entity Current Reporting Status | 'Yes | ' |
Entity Filer Category | 'Large Accelerated Filer | ' |
Entity Common Stock, Shares Outstanding | ' | 31,521,608 |
Document Fiscal Year Focus | '2013 | ' |
Document Fiscal Period Focus | 'Q3 | ' |
Condensed_Consolidated_Balance
Condensed Consolidated Balance Sheets (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Current assets: | ' | ' |
Cash and cash equivalents | $219,232 | $269,157 |
Marketable securities | 238,097 | 140,069 |
Accounts receivable, net of allowance for doubtful accounts of $334 | 35,671 | 30,921 |
Inventories | 77,722 | 65,926 |
Income taxes receivable | 4,131 | 1,566 |
Deferred taxes | 13,451 | 14,988 |
Prepaid expenses and other current assets | 2,960 | 2,761 |
Total current assets | 591,264 | 525,388 |
Property and equipment, net | 40,083 | 36,294 |
Deferred taxes | 2,066 | 709 |
Other assets | 8,869 | 11,172 |
Total assets | 642,282 | 573,563 |
Current liabilities: | ' | ' |
Accounts payable | 5,797 | 3,205 |
Accrued commissions | 1,732 | 1,645 |
Accrued payroll and benefits | 5,235 | 3,726 |
Accrued other expenses | 5,291 | 7,518 |
Income taxes payable | 206 | 584 |
Customer advances | 2,373 | 1,909 |
Deferred revenue | 2,801 | 2,790 |
Total current liabilities | 23,435 | 21,377 |
Long-term income taxes payable | 4,964 | 412 |
Deferred taxes | 348 | 446 |
Other liabilities | 108 | 124 |
Total liabilities | 28,855 | 22,359 |
Commitments and contingencies (Note 5) | ' | ' |
Stockholders' equity: | ' | ' |
Preferred stock, $.01 par value: 5,000 shares authorized; no shares issued or outstanding at September 30, 2013 and December 31, 2012 | ' | ' |
Common stock, $.01 par value: 200,000 shares authorized; 31,519 and 31,563 shares issued and outstanding at September 30, 2013 and December 31, 2012, respectively | 315 | 316 |
Additional paid-in capital | 201,199 | 189,273 |
Accumulated other comprehensive loss | -1,392 | -464 |
Retained earnings | 413,305 | 362,079 |
Total stockholders' equity | 613,427 | 551,204 |
Total liabilities and stockholders' equity | $642,282 | $573,563 |
Condensed_Consolidated_Balance1
Condensed Consolidated Balance Sheets (Parenthetical) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, except Per Share data, unless otherwise specified | ||
Condensed Consolidated Balance Sheets | ' | ' |
Accounts receivable, allowance for doubtful accounts (in dollars) | $334 | $334 |
Preferred stock, par value (in dollars per share) | $0.01 | $0.01 |
Preferred stock, shares authorized | 5,000 | 5,000 |
Preferred stock, shares issued | 0 | 0 |
Preferred stock, shares outstanding | 0 | 0 |
Common stock, par value (in dollars per share) | $0.01 | $0.01 |
Common stock, shares authorized | 200,000 | 200,000 |
Common stock, shares issued | 31,519 | 31,563 |
Common stock, shares outstanding | 31,519 | 31,563 |
Condensed_Consolidated_Stateme
Condensed Consolidated Statements of Operations (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Condensed Consolidated Statements of Operations | ' | ' | ' | ' |
Revenue | $68,737 | $67,170 | $205,040 | $195,880 |
Cost of revenue | 19,808 | 17,762 | 56,538 | 51,119 |
Gross profit | 48,929 | 49,408 | 148,502 | 144,761 |
Operating expenses: | ' | ' | ' | ' |
Research and development | 11,994 | 12,549 | 37,941 | 36,753 |
Sales and marketing | 5,638 | 6,017 | 17,411 | 17,647 |
General and administrative | 3,298 | 3,290 | 10,491 | 11,130 |
Total operating expenses | 20,930 | 21,856 | 65,843 | 65,530 |
Income from operations | 27,999 | 27,552 | 82,659 | 79,231 |
Interest income | 59 | 39 | 193 | 103 |
Other income (expense), net | 46 | 13 | 140 | -114 |
Income before income taxes | 28,104 | 27,604 | 82,992 | 79,220 |
Provision for income taxes | 9,365 | 9,915 | 28,605 | 28,365 |
Net income | $18,739 | $17,689 | $54,387 | $50,855 |
Earnings per share: | ' | ' | ' | ' |
Basic (in dollars per share) | $0.61 | $0.58 | $1.78 | $1.68 |
Diluted (in dollars per share) | $0.60 | $0.57 | $1.75 | $1.65 |
Weighted average shares outstanding: | ' | ' | ' | ' |
Basic (in shares) | 30,619 | 30,361 | 30,589 | 30,345 |
Diluted (in shares) | 31,122 | 30,924 | 31,066 | 30,859 |
Condensed_Consolidated_Stateme1
Condensed Consolidated Statements of Comprehensive Income (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Condensed Consolidated Statements of Comprehensive Income | ' | ' | ' | ' |
Net income | $18,739 | $17,689 | $54,387 | $50,855 |
Foreign currency translation adjustments | 130 | 308 | -935 | 297 |
Unrealized gain on marketable securities, net of tax | 8 | 2 | 7 | 2 |
Comprehensive income | $18,877 | $17,999 | $53,459 | $51,154 |
Condensed_Consolidated_Stateme2
Condensed Consolidated Statements of Cash Flows (USD $) | 9 Months Ended | |
In Thousands, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 |
Cash flows from operating activities: | ' | ' |
Net income | $54,387 | $50,855 |
Adjustments to reconcile net income to net cash provided by operating activities: | ' | ' |
Depreciation | 6,383 | 6,011 |
Amortization | 1,896 | 3,158 |
Deferred taxes | 57 | -4,942 |
Provision for excess and obsolete inventory | 2,385 | 1,864 |
Stock-based compensation | 10,472 | 10,067 |
Changes in operating assets and liabilities: | ' | ' |
Accounts receivable | -4,785 | 2,359 |
Inventories | -14,181 | -23,424 |
Prepaid expenses and other assets | -214 | -848 |
Deferred revenue and customer advances | 474 | 44 |
Accounts payable | 2,608 | 596 |
Accrued expenses | -498 | 5,627 |
Income taxes receivable and payable | 1,609 | -3,160 |
Net cash provided by operating activities | 60,593 | 48,207 |
Cash flows from investing activities: | ' | ' |
Purchases of property and equipment | -10,569 | -9,487 |
Purchases of marketable securities | -397,873 | -50,119 |
Proceeds from sales and maturities of marketable securities | 300,000 | ' |
Net cash used in investing activities | -108,442 | -59,606 |
Cash flows from financing activities: | ' | ' |
Proceeds from exercise of stock options | 312 | 258 |
Payment of withholding taxes in connection with vesting of restricted stock | -3,162 | -321 |
Excess income tax benefit related to stock-based compensation plans | 1,141 | 340 |
Net cash (used in) provided by financing activities | -1,709 | 277 |
Effect of exchange rate changes on cash and cash equivalents | -367 | 181 |
Net decrease in cash and cash equivalents | -49,925 | -10,941 |
Cash and cash equivalents, beginning of period | 269,157 | 353,667 |
Cash and cash equivalents, end of period | $219,232 | $342,726 |
General
General | 9 Months Ended |
Sep. 30, 2013 | |
General | ' |
General | ' |
1. General | |
The interim condensed consolidated financial statements presented herein have been prepared by Hittite Microwave Corporation (the Company), are unaudited and, in the opinion of management, include all adjustments, consisting only of normal, recurring adjustments and accruals, necessary for a fair presentation of the Company’s financial position at September 30, 2013, results of operations for the three- and nine-month periods ended September 30, 2013 and 2012, comprehensive income for the three- and nine-month periods ended September 30, 2013 and 2012 and cash flows for the nine-month periods ended September 30, 2013 and 2012 in accordance with accounting principles generally accepted in the United States (GAAP). Interim results are not necessarily indicative of results for a full year. The condensed consolidated balance sheet presented as of December 31, 2012 has been derived from the audited consolidated financial statements as of that date but does not include all disclosures required by GAAP. | |
The condensed consolidated financial statements and notes are presented as permitted by Form 10-Q and do not contain all of the information that is included in the annual financial statements and notes of the Company. The condensed consolidated financial statements and notes presented herein should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012. | |
The Company operates in one reportable segment: the design, development and production of integrated circuits, modules, subsystems and instrumentation. | |
Recent_Accounting_Pronouncemen
Recent Accounting Pronouncements | 9 Months Ended |
Sep. 30, 2013 | |
Recent Accounting Pronouncements | ' |
Recent Accounting Pronouncements | ' |
2. Recent Accounting Pronouncements | |
In February 2013, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2013-02, “Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income.” ASU 2013-02 requires an entity to provide information about the amounts reclassified out of accumulated other comprehensive income by component. The Company adopted ASU 2013-02 effective January 1, 2013. Such adoption did not have a material effect on the Company’s financial position or results of operations. | |
Fair_Value_of_Financial_Instru
Fair Value of Financial Instruments | 9 Months Ended | |||||||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||||||
Fair Value of Financial Instruments | ' | |||||||||||||||||||||||||
Fair Value of Financial Instruments | ' | |||||||||||||||||||||||||
3. Fair Value of Financial Instruments | ||||||||||||||||||||||||||
The Company measures at fair value certain financial assets and financial liabilities. Fair value is the price that would be received for an asset, or the exit price that would be paid to transfer a liability, in the principal or most advantageous market in an orderly transaction between market participants on the measurement date. There are three levels of inputs used to measure fair value, arranged in a hierarchy that maximizes the use of observable inputs: | ||||||||||||||||||||||||||
Level 1: | Quoted prices (unadjusted) in active markets for identical assets or liabilities. | |||||||||||||||||||||||||
Level 2: | Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities. | |||||||||||||||||||||||||
Level 3: | Unobservable inputs that are supported by little or no market activity. | |||||||||||||||||||||||||
Assets and liabilities measured at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement requires judgment and considers factors specific to the asset or liability. The following table sets forth the Company’s financial assets that were measured at fair value within the fair value hierarchy: | ||||||||||||||||||||||||||
30-Sep-13 | December 31, 2012 | |||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
(in thousands) | ||||||||||||||||||||||||||
Cash equivalents | $ | 172,608 | $ | — | $ | — | $ | 172,608 | $ | 233,402 | $ | — | $ | — | $ | 233,402 | ||||||||||
Marketable securities | 238,097 | — | — | 238,097 | 140,069 | — | — | 140,069 | ||||||||||||||||||
Total | $ | 410,705 | $ | — | $ | — | $ | 410,705 | $ | 373,471 | $ | — | $ | — | $ | 373,471 | ||||||||||
Cash equivalents include money market funds as well as highly rated government securities with maturities of three months or less at the time of acquisition. The Company’s portfolio of marketable securities consists of treasury bills and treasury notes, which are classified as available-for-sale. Treasury bills and treasury notes consist of debt securities issued by the U.S. government. Gross unrealized gains and losses are immaterial for the periods presented. The effective maturity dates of these investments are less than one year. | ||||||||||||||||||||||||||
Inventories
Inventories | 9 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
Inventories | ' | |||||||
Inventories | ' | |||||||
4. Inventories | ||||||||
Net inventories consist of the following: | ||||||||
(in thousands) | 30-Sep-13 | December 31, 2012 | ||||||
Raw materials | $ | 50,169 | $ | 44,128 | ||||
Work in process | 12,811 | 8,289 | ||||||
Finished goods | 14,742 | 13,509 | ||||||
$ | 77,722 | $ | 65,926 | |||||
The Company is transitioning away from one of its foundries from which it sources a substantial portion of its GaAs wafers. The Company is working with the foundry to manage this transition with the goal of maintaining adequate supplies of the affected products over their natural life cycles, which are typically five to ten years. The Company has continued to make purchases of raw materials inventory from this foundry in order to support the products which have the longest life cycles. At September 30, 2013 and December 31, 2012, raw material inventory includes approximately $39,500,000 and $33,100,000, respectively, of advance purchases of wafers from this foundry. | ||||||||
Commitments_and_Contingencies
Commitments and Contingencies | 9 Months Ended |
Sep. 30, 2013 | |
Commitments and Contingencies | ' |
Commitments and Contingencies | ' |
5. Commitments and Contingencies | |
Indemnification | |
In connection with the sale of products in the ordinary course of business, the Company often makes representations affirming, among other things, that its products do not infringe on the intellectual property rights of others, and agrees to indemnify customers against third-party claims for such infringement. Further, the Company’s by-laws require it to indemnify its officers and directors against any action that may arise out of their services in that capacity, and the Company has also entered into indemnification agreements with respect to all of its directors. The Company has not been subject to any material liabilities under such provisions and therefore believes that its exposure for these indemnification obligations is minimal. Accordingly, the Company has no liabilities recorded for these indemnity agreements as of September 30, 2013 and December 31, 2012. | |
Product Warranties | |
The Company provides product warranties in conjunction with certain product sales. Generally, product sales are accompanied by a one-year warranty period. These warranties cover factors such as nonconformance to specifications and defects in material and workmanship. Estimated standard warranty costs are recorded in the period in which the related product sales occur. The Company’s warranty accrual and related expense were immaterial to the Company’s financial position and results of operations for the periods presented herein. | |
Intellectual Property Claims | |
In recent years there has been significant litigation involving intellectual property rights in many technology-based industries, including the Company’s. Because patent applications often are not disclosed until a patent is issued, it is not always possible for the Company to know whether patent applications are pending that might be infringed by its products, and there could be issued patents that are pertinent to the Company’s business of which it is not aware. The Company’s products may also be claimed to infringe intellectual property rights of others as a result of activities by its foundries or other suppliers with respect to which it has no control or knowledge. | |
The Company has from time to time been the subject of litigation alleging that sales by the Company of its products infringe patents held by such third parties. In addition, the Company has from time to time received letters asserting that it infringes patents held by third parties that have not resulted in litigation. The Company has incurred significant costs in investigating and defending intellectual property claims, and there can be no assurance that pending or future litigation or claims relating to infringement of third-party intellectual property rights can be resolved in a manner favorable to the Company. Claims relating to the alleged infringement by the Company of third-party proprietary rights, whether meritorious or not, could be time-consuming to defend and could harm the Company’s working relationships with its foundries and customers, damage its reputation, result in substantial and unanticipated costs associated with litigation, require the Company to enter into royalty or licensing agreements, which may not be available on acceptable terms or at all, or result in the payment by the Company of substantial damages. If any of the Company’s products were found to infringe the intellectual property rights of any third party and if a license were not available on reasonable terms, the Company could be required to redesign the infringing product so as not to infringe, which could be time consuming and costly, or if this is not feasible, could be required to withdraw the infringing product from the market. | |
Earnings_per_Share
Earnings per Share | 9 Months Ended | |||||||||||||
Sep. 30, 2013 | ||||||||||||||
Earnings per Share | ' | |||||||||||||
Earnings per Share | ' | |||||||||||||
6. Earnings per Share | ||||||||||||||
The following table sets forth the computation of basic and diluted net income per share: | ||||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||
(in thousands, except per share data) | 2013 | 2012 | 2013 | 2012 | ||||||||||
Basic earnings per share: | ||||||||||||||
Net income | $ | 18,739 | $ | 17,689 | $ | 54,387 | $ | 50,855 | ||||||
Weighted average common shares outstanding | 30,619 | 30,361 | 30,589 | 30,345 | ||||||||||
Basic earnings per share | $ | 0.61 | $ | 0.58 | $ | 1.78 | $ | 1.68 | ||||||
Diluted earnings per share: | ||||||||||||||
Net income | $ | 18,739 | $ | 17,689 | $ | 54,387 | $ | 50,855 | ||||||
Weighted average common shares outstanding | 30,619 | 30,361 | 30,589 | 30,345 | ||||||||||
Effect of dilutive equity awards | 503 | 563 | 477 | 514 | ||||||||||
Adjusted weighted average shares — diluted | 31,122 | 30,924 | 31,066 | 30,859 | ||||||||||
Diluted earnings per share | $ | 0.6 | $ | 0.57 | $ | 1.75 | $ | 1.65 | ||||||
The dilutive effect of outstanding equity awards, in the form of stock options, restricted stock awards and restricted stock units, is reflected in diluted earnings per share by application of the treasury stock method, which includes consideration of unamortized compensation cost and excess tax benefits on stock-based compensation. For all periods presented, an immaterial number of such securities were excluded from the calculation of diluted earnings per share, as their impact would have been anti-dilutive. | ||||||||||||||
StockBased_Compensation
Stock-Based Compensation | 9 Months Ended |
Sep. 30, 2013 | |
Stock-Based Compensation | ' |
Stock-Based Compensation | ' |
7. Stock-Based Compensation | |
On March 13, 2013, the Company announced that Stephen G. Daly would step down from the offices of chairman of the board, president and chief executive officer and that Rick D. Hess would be appointed as its new president and chief executive officer, each effective April 1, 2013. On April 1, 2013, the Company granted to Mr. Hess two restricted stock unit awards: (a) a time-vested restricted stock unit award, vesting in four equal annual installments, providing for the issuance to him, upon vesting in full, of 25,193 shares of the Company’s common stock, having a value on the date of grant equal to $1,500,000; and (b) a market-based restricted stock unit award providing for the issuance to him, provided that he remains employed by the Company on the fourth anniversary of the date of grant, of 25,193 shares of the Company’s common stock, having a value on the date of grant equal to $1,500,000 (the “target award”). The market conditions to which the target award is subject relate to the relative total shareholder return, or TSR, of the Company’s common stock over the four-year vesting period, in comparison to the TSRs of a group of comparable companies. The number of shares constituting the target award may be increased by up to 100% in the event that the Company’s TSR is positive and exceeds the 50th percentile in the comparison group. The number of shares to be issued upon vesting is capped such that the aggregate market value of the shares delivered will not exceed $4,500,000 as of the vesting date. The comparison group consists of the companies included in the Philadelphia Stock Exchange Semiconductor Sector (SOX) index, a capitalization-weighted index composed of companies primarily involved in the design, distribution, manufacture and sale of semiconductors. | |
The market-based restricted stock unit award has been classified as equity by the Company. The equity classification reflects the Company’s determination that it is not probable that the aggregate market value of the shares to be delivered upon vesting will be limited by the cap. The grant date fair market value of the market-based restricted stock unit award will be recognized as stock-based compensation over the four-year service term whether or not the market condition is ultimately satisfied. | |
Fair_Value_of_Financial_Instru1
Fair Value of Financial Instruments (Tables) | 9 Months Ended | |||||||||||||||||||||||||
Sep. 30, 2013 | ||||||||||||||||||||||||||
Fair Value of Financial Instruments | ' | |||||||||||||||||||||||||
Fair Value of Financial Assets and Liabilities | ' | |||||||||||||||||||||||||
30-Sep-13 | December 31, 2012 | |||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | |||||||||||||||||||
(in thousands) | ||||||||||||||||||||||||||
Cash equivalents | $ | 172,608 | $ | — | $ | — | $ | 172,608 | $ | 233,402 | $ | — | $ | — | $ | 233,402 | ||||||||||
Marketable securities | 238,097 | — | — | 238,097 | 140,069 | — | — | 140,069 | ||||||||||||||||||
Total | $ | 410,705 | $ | — | $ | — | $ | 410,705 | $ | 373,471 | $ | — | $ | — | $ | 373,471 |
Inventories_Tables
Inventories (Tables) | 9 Months Ended | |||||||
Sep. 30, 2013 | ||||||||
Inventories | ' | |||||||
Schedule of inventories | ' | |||||||
(in thousands) | 30-Sep-13 | December 31, 2012 | ||||||
Raw materials | $ | 50,169 | $ | 44,128 | ||||
Work in process | 12,811 | 8,289 | ||||||
Finished goods | 14,742 | 13,509 | ||||||
$ | 77,722 | $ | 65,926 | |||||
Earnings_per_Share_Tables
Earnings per Share (Tables) | 9 Months Ended | |||||||||||||
Sep. 30, 2013 | ||||||||||||||
Earnings per Share | ' | |||||||||||||
Earnings per Share | ' | |||||||||||||
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||
(in thousands, except per share data) | 2013 | 2012 | 2013 | 2012 | ||||||||||
Basic earnings per share: | ||||||||||||||
Net income | $ | 18,739 | $ | 17,689 | $ | 54,387 | $ | 50,855 | ||||||
Weighted average common shares outstanding | 30,619 | 30,361 | 30,589 | 30,345 | ||||||||||
Basic earnings per share | $ | 0.61 | $ | 0.58 | $ | 1.78 | $ | 1.68 | ||||||
Diluted earnings per share: | ||||||||||||||
Net income | $ | 18,739 | $ | 17,689 | $ | 54,387 | $ | 50,855 | ||||||
Weighted average common shares outstanding | 30,619 | 30,361 | 30,589 | 30,345 | ||||||||||
Effect of dilutive equity awards | 503 | 563 | 477 | 514 | ||||||||||
Adjusted weighted average shares — diluted | 31,122 | 30,924 | 31,066 | 30,859 | ||||||||||
Diluted earnings per share | $ | 0.6 | $ | 0.57 | $ | 1.75 | $ | 1.65 |
General_Details
General (Details) | 9 Months Ended |
Sep. 30, 2013 | |
item | |
General | ' |
Number of reportable segments | 1 |
Fair_Value_of_Financial_Instru2
Fair Value of Financial Instruments (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
In Thousands, unless otherwise specified | ||
Fair value of financial instruments | ' | ' |
Marketable securities | $238,097 | $140,069 |
Level 1 | ' | ' |
Fair value of financial instruments | ' | ' |
Cash equivalents | 172,608 | 233,402 |
Marketable securities | 238,097 | 140,069 |
Total | 410,705 | 373,471 |
Total | ' | ' |
Fair value of financial instruments | ' | ' |
Cash equivalents | 172,608 | 233,402 |
Marketable securities | 238,097 | 140,069 |
Total | $410,705 | $373,471 |
Inventories_Details
Inventories (Details) (USD $) | Sep. 30, 2013 | Dec. 31, 2012 |
Inventories | ' | ' |
Raw materials | $50,169,000 | $44,128,000 |
Work in process | 12,811,000 | 8,289,000 |
Finished goods | 14,742,000 | 13,509,000 |
Total | 77,722,000 | 65,926,000 |
Advance wafer purchases | $39,500,000 | $33,100,000 |
Earnings_per_Share_Details
Earnings per Share (Details) (USD $) | 3 Months Ended | 9 Months Ended | ||
In Thousands, except Per Share data, unless otherwise specified | Sep. 30, 2013 | Sep. 30, 2012 | Sep. 30, 2013 | Sep. 30, 2012 |
Basic earnings per share | ' | ' | ' | ' |
Net income | $18,739 | $17,689 | $54,387 | $50,855 |
Weighted average common shares outstanding | 30,619 | 30,361 | 30,589 | 30,345 |
Basic earnings per share (in dollars per share) | $0.61 | $0.58 | $1.78 | $1.68 |
Diluted earnings per share | ' | ' | ' | ' |
Net income | $18,739 | $17,689 | $54,387 | $50,855 |
Weighted average common shares outstanding | 30,619 | 30,361 | 30,589 | 30,345 |
Effect of dilutive equity awards (in shares) | 503 | 563 | 477 | 514 |
Adjusted weighted average shares-diluted | 31,122 | 30,924 | 31,066 | 30,859 |
Diluted earnings per share (in dollars per share) | $0.60 | $0.57 | $1.75 | $1.65 |
StockBased_Compensation_Detail
Stock-Based Compensation (Details) (Mr. Hess, USD $) | 0 Months Ended |
Apr. 02, 2013 | |
item | |
Restricted stock units | ' |
Equity | ' |
Number of awards issuable | 2 |
Time-vested restricted stock units | ' |
Equity | ' |
Number of installments in which awards will vest | 4 |
Number of shares authorized | 25,193 |
Grant date value of the shares authorized | $1,500,000 |
Vesting period | '4 years |
Market-based restricted stock units | ' |
Equity | ' |
Number of shares authorized | 25,193 |
Grant date value of the shares authorized | 1,500,000 |
Vesting period | '4 years |
Maximum percentage increase in number of shares to be issued in the event where Company's TSR is positive and exceeds the 50th percentile in the comparison group | 100.00% |
Number of shares vesting unless the Company's TSR over the 4-year vesting period is positive | 0 |
Capped market value of the shares to be issued | $4,500,000 |